“MBS’s recovery should be a strong read-through for GENS, though it tends to lag that of MBS,” she adds.
CLSA analyst Sue Lin Lim has upgraded Genting Singapore (GENS) (SGX:G13) to a “buy” call after Las Vegas Sands (LVS) released its results for the 2QFY2023 ended June. Lim has kept her target price unchanged at $1.26.
“LVS’s earnings call indicated the Singapore gaming industry continued to chart progress towards recovery as visitations improved with increases in flight capacity,” Lim writes in her report dated July 20.

